Free radical injury and antioxidant status in patients with benign prostate hyperplasia and prostate cancer
- 38 Downloads
Reactive oxygen species and other free radicals are known to be the mediators of phenotypic and genotypic changes that lead from mutation to neoplasia. There are some primary antioxidants such as glutathione peroxidase (GPx), glutathione S-transferases (GSTs) and reduced glutathione, which protect against callular and molecular damage caused by the reactive oxygen metabolites (ROMs). The present study was conducted to determine the level of malondialdehyde (MDA), as an index of lipid peroxidation, along with the GPx, GSTs activities and level of reduced glutathione in 45 prostate cancer (PC) patients, 55 benign prostate hyperplasia (BPH) patients as compared to the controls. Significant higher levels of MDA and GSTs activities in the serum, (P<0.005) and significant lower levels of reduced GSH concentration and GPx activity in blood haemolysates (P<0.05) of PC and BPH patients were observed as compared to the controls. The relatively higher GSTs activity and low level of reduced GSH may be due to the response of increased reactive oxygen metabolites production in the blood. The higher MDA and lower GPx activities may be inadequate to detoxify high levels of H2O2 into H2O leading to the formation of the*OH radical followed by MDA. This result hypothesizes that oxidant-antioxidant imbalance may be one of the major factor responsible for the development of prostate cancer and benign prostate hyperplasia.
Key WordsAntioxidant enzymes Benign prostate hyperplasia Prostate cancer Reactive oxygen species
Unable to display preview. Download preview PDF.
- 9.Yoshioka, T., Kawada, K., Shimada, T. and Mori, M. (1979) Lipid peroxidation in maternal and cord blood and protective mechanisms against activated oxygen toxicity in the blood. Am. J. Obster. Gynecology. 135, 372–376.Google Scholar
- 11.Beutler, E., Duron, O., and Kelly, B.M. (1961) Improved method for the determination of blood glutathione. J. Lab. and Clin. Med. May, 882–888.Google Scholar
- 14.Kitly, C.G. and Doyle, S.M. (1996). Glutathione S-transferases as a biomarkers of organ viability and damage. In: Vermeulen, N.P.E., Mulder, G.J., Nieuwenhuyse, H., Peters, W.H.M. and Van Bladerns, P.J., editors, Glutathione S-transferases: structure function and clinical implication. London: Taylor and Francis. pp.249–58.Google Scholar
- 15.Lee, W.H., Morton, R.A., Epstein, J.I., Brooks, J.D., Campbell, P.A., Bova, G.S., Hsieh, W.S., Isaacs, W.B. and Nelson, W.G. (1994) Cytidine methylation of regulatory sequences near the piclass glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc. Natl. Acad. Sci. USA, 91 (24), 11733–11737.PubMedCrossRefGoogle Scholar